chr2-232891481-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_019850.3(NGEF):c.1149G>A(p.Glu383=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,612,726 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0061 ( 13 hom., cov: 33)
Exomes 𝑓: 0.00059 ( 7 hom. )
Consequence
NGEF
NM_019850.3 synonymous
NM_019850.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.02
Genes affected
NGEF (HGNC:7807): (neuronal guanine nucleotide exchange factor) Enables guanyl-nucleotide exchange factor activity. Predicted to be involved in several processes, including activation of GTPase activity; ephrin receptor signaling pathway; and negative regulation of dendritic spine morphogenesis. Predicted to be located in cytosol. Predicted to be active in glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 2-232891481-C-T is Benign according to our data. Variant chr2-232891481-C-T is described in ClinVar as [Benign]. Clinvar id is 770514.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.02 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00613 (934/152360) while in subpopulation AFR AF= 0.0212 (883/41582). AF 95% confidence interval is 0.0201. There are 13 homozygotes in gnomad4. There are 445 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NGEF | NM_019850.3 | c.1149G>A | p.Glu383= | synonymous_variant | 8/15 | ENST00000264051.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NGEF | ENST00000264051.8 | c.1149G>A | p.Glu383= | synonymous_variant | 8/15 | 1 | NM_019850.3 | ||
NGEF | ENST00000373552.8 | c.873G>A | p.Glu291= | synonymous_variant | 6/13 | 2 | P1 | ||
NGEF | ENST00000416114.3 | c.318G>A | p.Glu106= | synonymous_variant | 4/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00613 AC: 933AN: 152242Hom.: 13 Cov.: 33
GnomAD3 genomes
AF:
AC:
933
AN:
152242
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00152 AC: 380AN: 249372Hom.: 6 AF XY: 0.00109 AC XY: 148AN XY: 135202
GnomAD3 exomes
AF:
AC:
380
AN:
249372
Hom.:
AF XY:
AC XY:
148
AN XY:
135202
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000594 AC: 867AN: 1460366Hom.: 7 Cov.: 31 AF XY: 0.000509 AC XY: 370AN XY: 726458
GnomAD4 exome
AF:
AC:
867
AN:
1460366
Hom.:
Cov.:
31
AF XY:
AC XY:
370
AN XY:
726458
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00613 AC: 934AN: 152360Hom.: 13 Cov.: 33 AF XY: 0.00597 AC XY: 445AN XY: 74510
GnomAD4 genome
AF:
AC:
934
AN:
152360
Hom.:
Cov.:
33
AF XY:
AC XY:
445
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 14, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at